Welcome to our dedicated page for Merlin SEC filings (Ticker: BACQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Merlin's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Merlin's regulatory disclosures and financial reporting.
Inflection Point Acquisition Corp. IV (NASDAQ: BACQ) reported shareholder approval of two proposals at an extraordinary general meeting on October 21, 2025. Shareholders approved changing the company’s name from “Bleichroeder Acquisition Corp. I” to “Inflection Point Acquisition Corp. IV” and an amendment to the Articles permitting the company to redeem public shares earlier in connection with commencing procedures to consummate a proposed business combination if the board determines it is desirable.
A quorum of 27,386,442 (81.125%) issued and outstanding ordinary shares was present, including 19,053,109 Class A and 8,333,333 Class B shares as of the September 15, 2025 record date. The name change passed with 27,386,302 For, 125 Against, 15 Abstain. The Article 50.5 amendment passed with 24,204,477 For, 160 Against, 201 Abstain. An adjournment vote was not required.
Bleichroeder Acquisition Corp. I is soliciting shareholder action at an Extraordinary General Meeting to be held October 21, 2025 at 10:00 a.m. New York Time, at White & Case LLP and via live webcast. Shareholders will vote on a proposed corporate name change, an amendment referred to as the Article 50.5 Amendment, and an adjournment proposal. The proxy explains the cash Redemption Price calculation: the aggregate amount on deposit in the Trust Account, including interest (net of taxes), divided by issued Public Shares, calculated two business days before consummation of a Business Combination. The filing discloses that certain officers resigned in July 2025 and a new management team affiliated with Inflection Point Fund I LP was appointed; a name change is proposed in connection with these changes.
Bleichroeder Acquisition Corp. I filed a Form 8-K reporting a material event via a press release dated September 23, 2025. The filing discloses the company's publicly traded units and related securities: Units (each consisting of one Class A ordinary share and one right), trading under BACQU; Class A ordinary shares trading under BACQ; and Rights (each right exercisable for one-tenth of one Class A share) trading under BACQR. The document includes an Interactive Data File and is signed by Michael Blitzer, President and Chief Executive Officer. The filing itself is a notice of a material event and the attached press release; it does not include financial results or transaction terms in the provided text.
Bleichroeder Acquisition Corp. I (BACQ) filed a preliminary proxy describing an Extraordinary General Meeting to vote on a proposed corporate name change, an amendment labeled the Article 50.5 Amendment, and an adjournment proposal. The filing discloses that certain officers resigned in July 2025 and a new management team affiliated with Inflection Point Fund I LP was appointed, and the company proposes to effect a name change in connection with these changes. It details IPO redemption mechanics: a cash per-share Redemption Price equal to the trust account balance (net interest) divided by then-issued public shares calculated two business days before consummation of the Business Combination. The proxy includes meeting logistics, quorum and voting rules, broker non-vote treatment, and standard forward-looking statement cautionary language.